title: Sustained remission of segmental myoclonus due to peripheral nerve injury after treatment with onabotulinumtoxinA.
authors.affiliation: Department of Neurology, Haga Teaching Hospital, The Hague, The Netherlands; Department of Clinical Neurophysiology, Haga Teaching Hospital, The Hague, The Netherlands. Electronic address: j.rath@hagaziekenhuis.nl.
authors.forename: Judith J G
authors.initials: JJ
authors.lastname: Rath
authors.affiliation: Department of Neurology, Haga Teaching Hospital, The Hague, The Netherlands; Department of Clinical Neurophysiology, Haga Teaching Hospital, The Hague, The Netherlands. Electronic address: d.tavy@hagaziekenhuis.nl.
authors.forename: Dénes L J
authors.initials: DL
authors.lastname: Tavy
authors.affiliation: Department of Neuropediatrics, Haga Teaching Hospital, The Hague, The Netherlands. Electronic address: i.snoeck-streef@hagaziekenhuis.nl.
authors.forename: Irina
authors.initials: I
authors.lastname: Snoeck-Streef
authors.affiliation: Department of Neurology, Haga Teaching Hospital, The Hague, The Netherlands; Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: m.f.contarino@amc.uva.nl.
authors.forename: M Fiorella
authors.initials: MF
authors.lastname: Contarino
mesh_terms: D065087:Acetylcholine Release Inhibitors / Q000627:therapeutic use*; D000293:Adolescent; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009207:Myoclonus / Q000188:drug therapy* / Q000209:etiology*; D059348:Peripheral Nerve Injuries / Q000150:complications* / Q000188:drug therapy
chemical_list: D065087:Acetylcholine Release Inhibitors; D019274:Botulinum Toxins, Type A
keywords: Complete sustained remission; OnabotulinumtoxinA; Peripheral myoclonus